abstract |
The present invention relates to a pharmaceutical composition containing 4-aminoquinoline compounds and Magnesium chloride for treatment of ocular inflammation of varied etiology such as immune disease factors, surgery, chemical or mechanical injury or prevention of injury due to exposure to radiation, infra-red or ultra-violet rays, degenerative changes, allergic or infective etiology using the novel pharmaceutical composition of the present invention. |